Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.
Public ClinicalTrials.gov record NCT04729595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Tempol (MBM-02) in Subjects With COVID-19 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An Adaptive, Randomized, Double-blind, Placebo-controlled study to examine the Effects of Tempol in subjects with COVID-19 infection.
Study identification
- NCT ID
- NCT04729595
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 248 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2021 (Actual)
- Primary completion
- Sep 21, 2022 (Actual)
- Completion
- Sep 21, 2022 (Actual)
- Last update posted
- Dec 6, 2022
2021 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group | Anniston | Alabama | 36207 | — |
| LA Universal Research | Los Angeles | California | 90057 | — |
| Doral medical Research | Doral | Florida | 33166 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Omega Research Orlando, LLC | Orlando | Florida | 32808 | — |
| Sunrise Research Institute | Sunrise | Florida | 33325 | — |
| Center for Respiratory and Sleep Medicine | Greenwood | Indiana | 46143 | — |
| Tandem Clinical Research GI, LLC. | Marrero | Louisiana | 70072 | — |
| Barrett Clinical | La Vista | Nebraska | 68128 | — |
| Monroe Biomedical Research | Monroe | North Carolina | 28112 | — |
| Dayton Clinical Research | Dayton | Ohio | 45406 | — |
| Clinical Trials Center of Middle Tennessee, LLC | Franklin | Tennessee | 37067 | — |
| Vilo Research Group | Houston | Texas | 77017 | — |
| United Memorial Medical Center | Houston | Texas | 77091 | — |
| R&H Clinical Research | Katy | Texas | 77494 | — |
| Meridian Clinical Research | Portsmouth | Virginia | 23707 | — |
| Eastside Research Associates | Redmond | Washington | 98052 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04729595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2022 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04729595 live on ClinicalTrials.gov.